340B Drug Pricing Program
A federal court today denied the Department of Health and Human Services’ motion for a stay in a lawsuit challenging the excessive delay in the effective date for the 340B price transparency rule.
Tom Nickels
Executive Vice President
The Department of Health and Human Services today proposed implementing on Jan. 1 its final rule on 340B drug ceiling prices and civil monetary penalties for manufacturers.
Melinda Hatton
On October 25, the Centers for Medicare & Medicaid Services issued an advance notice of proposed rulemaking to solicit public comments on potential options for testing a new model for paying for prescription drugs under Medicare Part B provided in physician offices, hospital outpatient…
AHA v. The Department of Health and Human Services Reply in Support of Defendants' Motion for a Stay
IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA
THE AMERICAN HOSPITAL ASSOCIATION, et al., Plaintiffs,
v.
THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, et al., Defendants.
No. 1:18-cv-02112-JDB
REPLY IN SUPPORT OF DEFENDANTS’ MOTION FOR A STAY
The AHA and other hospital groups today opposed the Department of Health and Human Services motion to stay in the groups’ lawsuit challenging the excessive delay in the effective date for the 340B price transparency rule.
Testimony for House Committee on Energy and Commerce Subcommittee on Oversight and Investigations, October 11, 2017.
Testimony of Dr. Charles Daniels House Energy and Commerce Committee 340B Oversight Hearing, July 11, 2018.